Clinician perspectives on preemptive pharmacogenetic testing to guide chemotherapy dosing in patients with gastrointestinal malignancies.

被引:0
|
作者
Lau-Min, Kelsey S. [1 ]
Varughese, Lisa A. [2 ]
Nelson, Maria N. [3 ]
Cambareri, Christine [4 ]
Reddy, Nandi J. [5 ]
Oyer, Randall A. [5 ]
Teitelbaum, Ursina R. [1 ]
Tuteja, Sony [2 ]
机构
[1] Univ Penn, Dept Med, Div Hematol Oncol, Perelman Sch Med, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Med, Div Translat Med & Human Genet, Perelman Sch Med, Philadelphia, PA 19104 USA
[3] Univ Penn, Perelman Sch Med, Dept Family Med & Community Hlth, Mixed Methods Res Lab, Philadelphia, PA 19104 USA
[4] Hosp Univ Penn, Dept Pharm, 3400 Spruce St, Philadelphia, PA 19104 USA
[5] Penn Med Lancaster Gen Hlth, Ann B Barshinger Canc Inst, Lancaster, PA USA
关键词
D O I
10.1200/JCO.2021.39.3_suppl.54
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
54
引用
收藏
页数:3
相关论文
共 50 条
  • [41] Prospective evaluation of early discharge of patients with chemotherapy-induced febrile neutropenia and hematological malignancies.
    Wasi, P
    Henderson, N
    Hammond, C
    Walker, IR
    BLOOD, 2000, 96 (11) : 322A - 322A
  • [42] Comparative analysis of myeloid-derived suppressor cell (MDSC) subsets in patients with gastrointestinal (GI) malignancies.
    Duffy, Austin G.
    Zhao, Fei
    Fioraventi, Suzanne
    Greten, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [43] Comparative analysis of myeloid-derived suppressor cell (MDSC) subsets in patients with gastrointestinal (GI) malignancies.
    Duffy, Austin G.
    Zhao, Fei
    Fioraventi, Suzanne
    Greten, Tim
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [44] Gastrointestinal stromal tumors associated with other malignancies. Chance phenomenon or causal relationship? A series of 75 patients
    Orlandi, E.
    Mordenti, P.
    Porzio, R.
    Zaffignani, E.
    Stroppa, E. M.
    Capelli, P.
    Delfanti, R.
    Zangrandi, A.
    Nobili, E.
    Cavanna, L.
    ANNALS OF ONCOLOGY, 2016, 27
  • [45] In Gastrointestinal' cancers, patients perspectives on palliative chemotherapy: a prospective study
    Khatri, P.
    Kumari, P.
    ANNALS OF ONCOLOGY, 2016, 27 : 34 - 34
  • [46] The future is now: Implementation of standard of care, preemptive pharmacogenomic testing in patients with gastrointestinal cancers
    Hearst, Emily C.
    Martin, James L.
    Crooks, Kristy R.
    Greene, Casey S.
    Hess, Kaitlyn W.
    Johnson, Natalie
    Kao, David P.
    Rafaels, Nicholas
    Carson, Katelyn
    Meguid, Cheryl L.
    Taucher, Kate
    Davis, S. Lindsey
    Lieu, Christopher Hanyoung
    Aquilante, Christina L.
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [47] Patient Attitudes toward Receiving Chemotherapy and Pharmacogenetic Testing in Curative and Palliative Cancer Patients
    Cuffe, Sinead
    Hon, Henrique
    Tobros, Kimberly
    Wong, Chung-Kwun Amy
    De Souza, Bradley
    McFarlane, Graham
    Masroor, Sohaib
    Hasani, Ekta
    Sun, Bin
    Di Tommaso, Natalie
    Xu, Wei
    Leighl, Natasha
    Alibhai, Shabbir
    Issa, Amalia
    Liu, Geoffrey
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2011, 20 : S327 - S328
  • [48] Ramosetron for the management of chemotherapy-induced gastrointestinal events in patients with hematological malignancies
    Zeng, XY
    Wang, AH
    Liu, YF
    Chen, Y
    Shen, Y
    Shen, ZX
    METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY, 2001, 23 (04): : 191 - 195
  • [49] Evaluation of a novel c-MET based circulating tumor cell (CTC) biomarker in patients with gastrointestinal malignancies.
    Zhang, Tian
    Boominathan, Rengasamy
    Foulk, Brad
    Connelly, Mark Carle
    Rao, Chandra
    Kemeny, Gabor
    Hurwitz, Herbert
    Garcia-Blanco, Mariano A.
    Armstrong, Andrew J.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (03)
  • [50] Once-weekly dosing of epoetin alfa increases hemoglobin (Hb) and improves quality of life (QOL) in patients with hematologic malignancies.
    Gabrilove, JL
    Einhorn, LH
    Cleeland, CS
    Livingston, RB
    Winer, E
    BLOOD, 1999, 94 (10) : 400A - 400A